Cisapride decreases gastric content aspiration in mechanically ventilated patients

Abstract

Objective: To determine the effect of the prokinetic agent cisapride in the prevention of aspiration of gastric contents. Design: A prospective randomized two-period crossover study. Setting: Fourteen-bed polyvalent intensive care unit in a University Hospital. Patients: Eighteen intubated, mechanically ventilated patients who were seated in a semirecumbent position were studied. Method: Tc-99m sulfur colloid (80 megabecquerels) was administered via nasogastric tube on 2 consecutive days. Patients randomly received cisapride (10 mg, via nasogastric tube) one day and a placebo the other. Bronchial secretions were obtained before and for 5 consecutive h after Tc-99m administration. The radioactivity was measured in a standard amount (1 ml) of bronchial fluid using a gamma counter and expressed as counts per min (cpm) after correction for decay. Results: Sixteen out of 18 (88%) patients had increased radioactivity in bronchial secretions. The radioactivity increased over time both with and without cisapride, although it was lower in patients receiving cisapride than in those receiving a placebo. The cumulative bronchial secretion radioactivity obtained when patients received cisapride was significantly lower than when patients received a placebo: 7540±5330 and 21965±16080 cpm, respectively (P<0.05). Conclusion: Our results suggest that aspiration of gastric contents exists even in patients who are kept in a semirecumbent position. Moreover, cisapride decreases the amount of gastric contents aspiration in intubated and mechanically ventilated patients and may play a role in the prevention of ventilator associated pneumonia. Cisapride, even with the patient in the semirecumbent position, did not completely prevent gastric content aspiration.